PeptideDB

Sibeprenlimab

CAS No.: 2382896-07-1

Sibeprenlimab (VIS649) is a humanized IgG 2 monoclonal antibody that suppresses APRIL. Sibeprenlimab has an inhibitory e
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Sibeprenlimab (VIS649) is a humanized IgG 2 monoclonal antibody that suppresses APRIL. Sibeprenlimab has an inhibitory effect on APRIL and may be studied for the prevention and treatment of kidney disease (IgAN).
Synonyms VIS649, VIS-649
molecular weight N/A
CAS 2382896-07-1
Storage store at low temperature | store at -80°C
References 1. Mohit Mathur, et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers. Kidney Int Rep. 2022 Feb 8;7(5):993-1003.